- August 13, 2021
Lykan and Vineti Form Cell Therapy Agreement
artnership will streamline process development and manufacturing to deliver therapies to patients in need.
- August 3, 2021
Uncharted Podcast #94, Democratizing healthcare and the importance of continuous learning with Amy DuRoss, CEO and Co-founder of Vineti by Uncharted Podcast
Amy DuRoss, CEO and Co-founder of Vineti, a committed patient advocate, is blazing a trail to orchestrate the supply chain...
- July 15, 2021
PharmaVoice 100 Entrepreneurs
These visionary leaders recognized an opportunity to fill an industry need and are successfully leading their companies to new heights.
- May 28, 2021
Industry News: Ori Biotech and Vineti have formed strategic partnership to deliver integrated manufacturing and supply chain solutions for cell and gene therapies
Ori Biotech, an innovator in cell and gene therapy manufacturing, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply…
- May 26, 2021
Ori Biotech and Vineti collaborate on digital platform for CGTs
Ori Biotech and Vineti are partnering to produce an integrated solution to streamline the manufacture and delivery of cell and gene therapies (CGTs).
Ori provides…
- April 20, 2021
McKesson Ventures highlights investment priorities amidst a trail of successful exits
McKesson Ventures is one of the most active investors in the biopharma software sector with Vineti, Komodo Health, Evidation and M2Gen among its portfolio companies.…
- April 8, 2021
Meeting on the Med 2021 | International collaboration in advanced therapies
Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, explains that the scientific community’s response to the COVID-19 pandemic has...
- April 8, 2021
Meeting on the Med 2021 | What can the field learn from the COVID-19 pandemic?
Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, discusses the lessons that the field of cell and gene therapy...
- April 1, 2021
Six Cell and Gene Therapy Commercialization Trends
Amy DuRoss, CEO and Co-founder, Vineti and Keith Martino, VP/General Manager, Biopharma Services, Cardinal Health Specialty Solutions discuss what to watch in the next 12…
- March 24, 2021
Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies
SAN FRANCISCO, March 24, 2021 (GLOBE NEWSWIRE) -- A broad coalition of biopharmaceutical and technology leaders today announced a new strategic collaboration to promote new…
- March 24, 2021
Exclusive: An industry consortium wants to standardize cell tracking for regenerative meds. Could that avert a disaster?
In the fast-moving world of regenerative medicine, the open secret among industry experts is that manufacturing is exceedingly difficult and will take a Herculean effort…
- March 15, 2021
Software for the cell and gene therapy wave: Vineti’s Amy DuRoss on The Long Run
We use cookies for analytics, marketing purposes, and to improve our site. You agree to our use of cookies by clicking yes. To find out more, including how to change your settings, see our privacy policy for details.